1/105
Looks like no tags are added yet.
Affective (mood) disorders
Imbalances of thought, mood and or behavior that interfere with the ability to function
DSM-5
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition; evidence-based manual with 297 mental illness diagnoses
Prevalence of mental illness among US adults
17.9 percent
Hallucinations
Sensory perceptions with a compelling sense of reality but no external stimulus. Perception abnormalities. Can be visual, auditory, olfactory or tactile.
Delusions
A false belief with persistent, unshakable acceptance of that false belief. Thought abnormalities.
Contrast hallucinations and delusions
Hallucinations = perception abnormalities (sensing something that is not there). Delusions = thought abnormalities (fixed false beliefs). They are not the same.
Visual hallucination pathway
Thalamic lateral geniculate nuclei processing to the visual association cortex
Auditory hallucination pathway
Thalamic medial geniculate nuclei processing to the auditory association cortex
What are the 2 types of visual hallucinations?
Release hallucinations and ictal hallucinations
Release hallucinations
Blocked normal sensory input so stored images are experienced
Ictal hallucinations
Mediated by abnormal neuronal discharges; visual ictal hallucinations are brief and geometric (epilepsy aura) but very complex when associated with other disorders
Auditory hallucinations
Misperceptions of sound such as tinnitus, buzzing, music or voices. Common in some types of schizophrenia, hearing impairment, right hemisphere damage and ethanol withdrawal.
Characteristics of psychiatric disorder-induced auditory hallucinations
Voices that are non-localized, comment on behavior, thought echoes; rarely supportive and usually critical and negative in tone
Contrast visual and auditory hallucinations
Visual = lateral geniculate to visual association cortex; release or ictal types; ictal ones are brief and geometric in epilepsy but complex in other disorders. Auditory = medial geniculate to auditory association cortex; voices, buzzing, tinnitus; critical voices in schizophrenia.
Delusions of persecution
Belief of personal threats against oneself
Delusions of influence
Belief that one's thoughts can influence people or objects
Delusions of ill health
False belief of having a serious illness
Delusions of grandeur
Belief that oneself is a great person (for example the Queen of England)
Delusions of poverty
False belief of being poor or destitute
Delusions of possession
Belief that one's body is possessed by a great power such as God or demons
What are the types of delusions commonly observed in psychiatric disorders?
Persecution, influence, ill health, grandeur, poverty and possession. They are formed from the individual's background (personal, family, social, education, culture and religion).
Acetylcholine in psychiatric disorders
Excitatory or inhibitory; learning and memory; basal ganglia and motor cortex; neurocognitive disorders (NCDs)
Dopamine in psychiatric disorders
Involuntary motor movement, mood states, reward systems and judgment; substantia nigra and ventral tegmental area of the midbrain; schizophrenia, mood disorders, anxiety disorders, substance use disorders and NCDs
Norepinephrine and epinephrine in psychiatric disorders
Learning and memory, reward systems; sympathetic nervous system; mood disorders and anxiety disorder
Serotonin in psychiatric disorders
Appetite, sleep, mood, hallucinations and pain perception; raphe nucleus in the brain stem; schizophrenia, mood disorders, anxiety disorders and NCDs
Amino acid neurotransmitters in psychiatric disorders
GABA, glutamate, aspartate and glycine; inhibit or excite neurons throughout the brain; schizophrenia, mood disorders, anxiety disorders, substance use disorders and NCDs
Corticotropin-releasing hormone (CRH) in psychiatric disorders
Activates fear behaviors and increases motor activity; hypothalamic-pituitary-adrenal (HPA) axis; mood disorders
Cortisol in psychiatric disorders
Mobilizes energy and increases arousal; hypothalamus; mood disorders
Where is the raphe nucleus and what does it do?
In the brain stem; the main source of serotonin neurons
Characterize the major neurotransmitters, regions and disorders
ACh = basal ganglia and motor cortex, NCDs. Dopamine = substantia nigra and VTA, schizophrenia, mood, anxiety, substance use. NE and Epi = sympathetic nervous system, mood and anxiety. Serotonin = raphe nucleus, schizophrenia, mood, anxiety. Amino acids = throughout brain. CRH and cortisol = HPA axis and hypothalamus, mood disorders.
How is schizophrenia characterized?
Delusions, hallucinations or false perceptions, psychosis (a break with reality), disjointed behavior and speech, limited emotions, and impaired reasoning and problem solving with social dysfunction
Diagnostic criteria for schizophrenia
Two or more psychotic manifestations that last 6 months before diagnosis
Epidemiology of schizophrenia
Affects 1 percent of the population; onset between 16 and 30 years of age; equal in males and females
Proposed risk factors for schizophrenia
Childhood trauma, malnutrition, long-term cannabis use, chronic amphetamine use, vitamin D deficiency, older fathers, latent persistent retrovirus infection, psychosocial determinants (poverty, migrant status) and a close relative with schizophrenia
Genetic risk in schizophrenia
First-degree relatives of a person with schizophrenia have a 10-fold greater prevalence of the illness than the general population
Positive (psychotic) symptoms of schizophrenia
Incomprehensible speech, hallucinations, delusions and grossly disorganized or catatonic behavior
Negative symptoms of schizophrenia
Absence of normal social and interpersonal behaviors, alogia, avolition, apathy, affective flattening and inappropriate affect, and anhedonia. Severe and persistent; treatment is difficult.
Alogia
Speaking very little (negative symptom)
Avolition
Lack of goal-oriented motivation (negative symptom)
Apathy
Lack of emotional expression (negative symptom)
Anhedonia
Pleasure no longer feels pleasurable (negative symptom)
Affective flattening
Reduced emotional expression with inappropriate affect (negative symptom)
Contrast positive and negative symptoms. Which tend to be worse?
Positive = added psychotic experiences (hallucinations, delusions, disorganized speech and behavior), respond better to treatment. Negative = loss of normal function (alogia, avolition, apathy, anhedonia), severe, persistent and hard to treat, so they tend to be worse.
Disorganization symptom cluster (labeled negative symptom on slide)
Catatonic excitement, echopraxia, regressed behavior, stereotypy, hypervigilance and waxy flexibility
Catatonic excitement
Hyperactive, purposeless activity with abnormal movements such as grimacing or posturing
Echopraxia
Imitation of another person's movement
Regressed behavior
Going back to behavior of another time
Stereotypy
Repetitive, idiosyncratic movements
Hypervigilance
Enhanced state of sensory stimulation
Waxy flexibility
Posture held in an odd fixed position for extended periods of time
What are the 3 major divisions of schizophrenia?
Paranoid, disorganized and catatonic
Paranoid schizophrenia
Sudden onset; persecutory and or grandiose delusions; auditory hallucinations; rigid, intense, controlled interactions; fewer negative symptoms
Disorganized schizophrenia
Personality disintegration; negative symptom predominance; withdrawn and inept; aimless behavior; neglect of personal grooming and daily activities
Catatonic schizophrenia
Rare; intense psychomotor disturbance (catatonic excitement or retardation); extreme negativism; grimacing, posturing and echolalia (repeating others)
Echolalia
Repeating the words of others
Contrast the 3 divisions of schizophrenia
Paranoid = delusions and auditory hallucinations, sudden onset, fewer negative symptoms. Disorganized = negative symptoms predominate, personality disintegration, neglect of grooming. Catatonic = rare, psychomotor disturbance, negativism, posturing, echolalia.
Neuropathophysiology of schizophrenia, neurotransmitters
Dysregulation of dopaminergic and serotonergic systems; decreased glutamatergic activity (NMDA receptor dysfunction); GABA deficits (lower GABA production in the dorsolateral prefrontal cortex, possibly from mRNA dysfunction)
Structural changes in schizophrenia
Excessive loss of cortical gray matter, abnormal cortical thinning, fewer synaptic structures, reduced dendritic spine density of pyramidal neurons in the prefrontal cortex, arrested migration of hippocampal neurons, enlarged lateral and third ventricles, reduced frontal lobe, temporal lobe and amygdala, and diminished neuronal content in the thalamus
Explain the neuropathophysiological mechanisms of schizophrenia
Neurochemical (dopamine and serotonin dysregulation, NMDA hypofunction, GABA deficit in the dorsolateral prefrontal cortex) plus structural (gray matter loss, cortical thinning, reduced dendritic spines, arrested hippocampal neuron migration, ventricular enlargement, thalamic neuron loss)
Major depressive disorder (MDD)
Loss of interest in previously enjoyed activities; recurring thoughts of suicide, lack of appetite, poor concentration, difficulty making decisions, worthlessness, low energy, decreased motor skills, substance abuse and sleep disturbances from insomnia to oversleeping
Diagnostic criteria for MDD
Symptoms present most of the day, nearly every day, for a minimum of 2 weeks and interfering with work or functioning
Persistent depressive disorder (dysthymia)
Chronic but mild depression lasting at least 2 years with a roller-coaster presentation. Needs at least two of altered sleep, fatigue, altered eating, poor concentration, poor self-esteem or hopelessness. Stress may play a role; cause is idiopathic.
Premenstrual dysphoric disorder (PMDD)
Hormonal fluctuation a few days to 2 weeks before menstruation causing exhaustion, anger, insecurity or loss of control, and lack of desire for relationships. Affects 3 to 8 percent of women, stops with menopause, cause idiopathic, and must not merely be an exacerbation of another psychiatric disorder.
Disruptive mood dysregulation disorder (DMDD)
Relatively new diagnosis in children and adolescents aged 6 to 18. Everyday anger and irritability most of the day, temper outbursts more than 3 times per week, difficulty interacting with others, present gradually over 12 or more months. Cause idiopathic.
Compare and contrast MDD, dysthymia, PMDD and DMDD
MDD = severe, 2 weeks minimum, most of the day nearly every day. Dysthymia = mild and chronic, at least 2 years. PMDD = cyclic, premenstrual, ends at menopause. DMDD = children and adolescents aged 6 to 18, chronic irritability and outbursts over 12 or more months.
Bipolar disorder
Mood swings from high (euphoria, mania) to low (depression). Major depression components must be met in addition to the cardinal symptom of mania. Lifetime prevalence about 2.5 percent, median onset age 25, higher frequency in women, often undiagnosed for 10 years.
What are the 3 main types of bipolar disorder?
Bipolar I, bipolar II and cyclothymia
How do you distinguish bipolar disorder from major depression?
Bipolar disorder includes mania or hypomania (elevated, expansive or irritable mood) in addition to depressive episodes, while major depression has only depressive episodes
Bipolar I disorder
One or more manic episodes (elevated, expansive or irritable mood) alternating with major depressive episodes. Mania is extreme with talkativeness, racing thoughts, grandiosity, distractibility, delusions, overactivity and risky behavior. Episodes begin suddenly and last days to months. Depression is more severe and less responsive to conventional therapy.
Bipolar II disorder
Major depressive episode plus at least one hypomanic or less severe manic episode. Hypomanic symptoms last at least 4 days.
Hypomania
Milder form of mania
Cyclothymia
Similar to type I but less severe. Hypomania and nonpsychotic depression for at least 2 years in adults (1 year in children and adolescents). Person does not meet criteria for a major depressive episode or manic episode (exclusion disorder).
Rapid cycling in bipolar disorder
Four or more manic episodes lasting at least 2 weeks in a year; remission is replaced with pronounced depressive symptoms
Compare and contrast bipolar I, bipolar II and cyclothymia
I = full manic episodes plus major depression, most severe, psychosis possible. II = hypomania plus major depression, no full mania. Cyclothymia = hypomania plus mild nonpsychotic depression for 2 years, never meets criteria for major depression or mania.
Neuropathophysiology of bipolar disorder
Linked to the same mechanisms as schizophrenia. Prefrontal cortex gray matter reduction with decreased activity; extensive prefrontal connections with the limbic system lead to mood dysregulation.
Gold standard treatment for bipolar disorder
Lithium (valproate and carbamazepine are also prescribed)
Explain the mechanism of lithium in bipolar disorder
Lithium inhibits inositol monophosphatase (IMPase) and inositol polyphosphate 1-phosphatase (IPP), depleting free inositol. This dampens phosphoinositide signaling (PLC, IP3 and DAG) in overactive neurons, stabilizing mood. Valproate and carbamazepine also act on the inositol pathway.
IMPase
Inositol-1 (or 4)-monophosphatase; enzyme in the inositol recycling pathway inhibited by lithium
IPP
Inositol-1,4 bisphosphate 1-phosphatase; enzyme in the inositol pathway
Ino-1
Inositol synthase
SMIT
Sodium and myo-inositol transporter
PLC
Phospholipase C
DAG
Diacylglycerol
InsP
Inositol phosphate
Anxiety disorders
Intense fearfulness without a precipitating potentially dangerous event. Most prevalent psychiatric disorders (18.1 percent); females are 60 percent more likely than males to experience one.
Subjective manifestations of anxiety disorders
Heightened awareness and deep fear of impending disaster or death
Objective manifestations of anxiety disorders
HPA axis-mediated sympathetic activation (fight-or-flight) with increased heart rate and blood pressure, dry mouth, palpitations, restlessness and sweating
Differences between subjective and objective anxiety manifestations
Subjective = what the person feels internally (heightened awareness, fear of disaster or death). Objective = measurable physical signs from sympathetic activation (heart rate, blood pressure, dry mouth, sweating, palpitations).
Generalized anxiety disorder (GAD)
Excessive anxiety and worry that is hard to control, most days for at least 6 months, interfering with daily life. Apprehension, anxiety, tension and autonomic hyperactivity causing fatigue, poor concentration and sleep disturbance. Often diagnosed at ages 45 to 59; 50 percent also experience depression.
Panic disorder
Unexpected surges of recurrent fear or intense discomfort (panic attacks). Prevalence 2 to 3 percent. Feelings of being out of control, fear of death, palpitations, sweats, chills, tingling or numbness, chest or stomach pain, dyspnea and nausea. Attacks last 15 to 30 minutes up to 1 hour.
Panic attack presentation in the ED
Chest pain and shortness of breath, so patients are initially seen for a suspected myocardial infarction
Compare and contrast GAD and panic disorder
GAD = chronic, persistent excessive worry lasting at least 6 months, autonomic hyperactivity, often ages 45 to 59. Panic disorder = sudden, unexpected attacks of intense fear peaking in minutes and lasting 15 to 60 minutes, with chest pain and fear of death.
Neuropathophysiology of anxiety disorders
Serotonergic under-activation and adrenergic over-activation. Major mediators are GABA, NE, serotonin and dopamine. Sympathetic nervous system and corticosteroid activation in the stress response. Panic is related to a hyperactive amygdala, limbic and prefrontal cortex (fear networks), regulated by increased glutamatergic activity.
First-line treatments for anxiety disorders
SSRIs or SNRIs, or 5-HT1A agonists
Second-line and rescue treatments for anxiety disorders
Benzodiazepines
Fear networks
Hyperactive amygdala, limbic system and prefrontal cortex thought to underlie panic disorder
Wernicke-Korsakoff syndrome
Affective-like disorder resulting from chronic alcohol use. Ethanol-induced brain lesions precipitate the symptoms.
What causes Wernicke-Korsakoff syndrome?
Chronic alcohol use, mainly through thiamine (vitamin B1) deficiency that interferes with glucose metabolism in the brain
Brain lesions in Wernicke-Korsakoff syndrome
Cortical atrophy (progressive degeneration of the cortex), hydrocephalus ex vacuo (compensatory enlargement of CSF spaces) and cerebellar vermicular atrophy (degeneration of the cerebellar midline)
Cortical atrophy
Progressive degeneration of the cortex